Cargando…
A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
Nanobodies are camelid-derived single-domain antibodies that present some advantages versus conventional antibodies, such as a smaller size, and higher tissue penetrability, stability, and hydrophilicity. Although nanobodies can be delivered as proteins, in vivo expression from adeno-associated vira...
Autores principales: | Silva-Pilipich, Noelia, Smerdou, Cristian, Vanrell, Lucía |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465657/ https://www.ncbi.nlm.nih.gov/pubmed/34576851 http://dx.doi.org/10.3390/microorganisms9091956 |
Ejemplares similares
-
Long-Term Systemic Expression of a Novel PD-1 Blocking Nanobody from an AAV Vector Provides Antitumor Activity without Toxicity
por: Silva-Pilipich, Noelia, et al.
Publicado: (2020) -
Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors
por: Silva-Pilipich, Noelia, et al.
Publicado: (2023) -
A new generation of vaccines based on alphavirus self-amplifying RNA
por: Ballesteros-Briones, María Cristina, et al.
Publicado: (2020) -
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
por: Eichhoff, Anna Marei, et al.
Publicado: (2019) -
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs
por: Pinto-Espinoza, Carolina, et al.
Publicado: (2022)